Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naftopidil for medical expulsive therapy in ureteral stones
KCT0001289Phase 3Completed
- Sponsor
- Dong-A ST
- Start
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of naftopidil in ureterolithiasis, sponsored by Dong-A ST. Started May 2014; status: completed.
02
Drugs
naftopidil
03
Conditions
ureterolithiasis
Beyond the preview
Go deeper on KCT0001289.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0001289.